BACKGROUND: Concentrations of interleukin (IL)-18 increase in the circulation of human immunodeficiency virus (HIV)-infected persons. However, nothing is known concerning the regulation of IL-18-binding protein (IL-18BP), which neutralizes IL-18 in vivo. This issue is addressed in the present study. METHODS: Serum samples obtained from healthy subjects and HIV-infected patients were analyzed by enzyme-linked immunosorbent assay to determine their IL-18 and IL-18BP contents. Human monocyte-derived macrophages (MDMs) were infected in vitro with HIV type 1 (HIV-1), and the production of these 2 cytokines by these cells was measured. Finally, we determined the effect of IL-18 on HIV-1 replication in human cells. RESULTS: In contrast to IL-18 levels, IL-18BP levels decreased in the serum of HIV-infected patients. This decrease resulted in enhanced levels of free IL-18 in the serum of such patients. The infection increased production of IL-18 but decreased that of IL-18BP in MDMs. IL-10 and transforming growth factor-beta, concentrations of which are increased in HIV-infected persons, also decreased production of IL-18BP by human MDMs. Finally, recombinant human IL-18 enhanced HIV-1 replication in human CD4(+) T cells. CONCLUSIONS: Production of IL-18 and its antagonist becomes imbalanced in HIV-1-infected persons. The infection and the cytokine milieu play a role in this decreased production. The increased biological activities of IL-18 may enhance viral replication in human CD4(+) T cells.
BACKGROUND: Concentrations of interleukin (IL)-18 increase in the circulation of humanimmunodeficiency virus (HIV)-infectedpersons. However, nothing is known concerning the regulation of IL-18-binding protein (IL-18BP), which neutralizes IL-18 in vivo. This issue is addressed in the present study. METHODS: Serum samples obtained from healthy subjects and HIV-infectedpatients were analyzed by enzyme-linked immunosorbent assay to determine their IL-18 and IL-18BP contents. Human monocyte-derived macrophages (MDMs) were infected in vitro with HIV type 1 (HIV-1), and the production of these 2 cytokines by these cells was measured. Finally, we determined the effect of IL-18 on HIV-1 replication in human cells. RESULTS: In contrast to IL-18 levels, IL-18BP levels decreased in the serum of HIV-infectedpatients. This decrease resulted in enhanced levels of free IL-18 in the serum of such patients. The infection increased production of IL-18 but decreased that of IL-18BP in MDMs. IL-10 and transforming growth factor-beta, concentrations of which are increased in HIV-infectedpersons, also decreased production of IL-18BP by human MDMs. Finally, recombinant humanIL-18 enhanced HIV-1 replication in humanCD4(+) T cells. CONCLUSIONS: Production of IL-18 and its antagonist becomes imbalanced in HIV-1-infectedpersons. The infection and the cytokine milieu play a role in this decreased production. The increased biological activities of IL-18 may enhance viral replication in humanCD4(+) T cells.
Authors: Michael A Chattergoon; Jordana S Levine; Rachel Latanich; William O Osburn; David L Thomas; Andrea L Cox Journal: J Infect Dis Date: 2011-10-07 Impact factor: 5.226
Authors: Aaron F Carlin; Paula Aristizabal; Qinghua Song; Huan Wang; Matthew S Paulson; Luisa M Stamm; Robert T Schooley; David L Wyles Journal: Hepatology Date: 2015-08-22 Impact factor: 17.425
Authors: Kathy Triantafilou; Christopher J K Ward; Magdalena Czubala; Robert G Ferris; Emma Koppe; Curt Haffner; Vincent Piguet; Vipulkumar K Patel; Heather Amrine-Madsen; Louise K Modis; Seth L Masters; Martha Triantafilou Journal: PLoS Pathog Date: 2021-04-16 Impact factor: 6.823
Authors: Andrew E Armitage; Andrea R Stacey; Eleni Giannoulatou; Elizabeth Marshall; Pamela Sturges; Kamaljit Chatha; Nicola M G Smith; XiaoJie Huang; XiaoNing Xu; Sant-Rayn Pasricha; Ning Li; Hao Wu; Craig Webster; Andrew M Prentice; Pierre Pellegrino; Ian Williams; Phillip J Norris; Hal Drakesmith; Persephone Borrow Journal: Proc Natl Acad Sci U S A Date: 2014-08-04 Impact factor: 11.205